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Abstract
Background: Herbal supplements are widely used in the treatment of various liver disases, but some of them may
also induce liver injuries. Regarding the infuence of thyme and its constituents on the liver, conflicting results have
been reported in the literature. The objective of this study was to examine the influence of two commonly used
pharmaceutical formulations containing thyme (Thymus vulgaris L.), tincture and syrup, on carbon tetrachloride-
induced acute liver injury in rats.
Methods: Chemical composition of investigated formulations of thyme was determined by gas chromatography
and mass spectrometry. Activities of enzyme markers of hepatocellular damage in serum and antioxidant enzymes
in the liver homogenates were measured using the kinetic spectrophotometric methods. Liver morphology was
characterized by light microscopy using routine hematoxylin and eosin staining.
Results: Thymol was found to be predominant active constituent in both tincture and syrup. Investigated thyme
preparations exerted antioxidant effects in liver by preventing carbon tetrachloride-induced increase of lipid
peroxidation. Furthermore, co-treatment with thyme preparations reversed the activities of oxidative stress-related
enzymes xanthine oxidase, catalase, peroxidase, glutathione peroxidase and glutathione reductase, towards normal
values in the liver. Hepatotoxicity induced by carbon tetrachloride was reflected by a marked elevation of AST and ALT
activities, and histopathologic alterations. Co-administration of thyme tincture resulted in unexpected exacerbation of
AST and ALT values in serum, while thyme syrup managed to reduce activites of aminotransferases, in comparison to
carbon tetrachloride-treated animals.
Conclusions: Despite demonstrated antioxidant activity, mediated through both direct free radical scavenging and
activation of antioxidant defense mechanisms, thyme preparations could not ameliorate liver injury in rats. Molecular
mechanisms of diverse effects of thyme preparations on chemical-induced hepatotoxicity should be more in-depth
investigated.
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Background
Herbal medicinal products are increasingly being used
and many of them have shown promising potential for the
treatment of various diseases. However, many of herbal
medicines remain untested and their use also not moni-
tored, which makes knowledge of their safety very limited
[1]. Besides, herbal medicines are widely promoted as
being ‘natural’, and therefore are perceived to be ‘safe’,
which is not only untrue, but also misleading [2].
The liver is highly susceptible to drug-induced toxicity
due to its significant role primarily in drug metabolism.
The pathophysiological mechanisms of drug-induced hep-
atotoxicity are still to be elucidated, but are mostly initi-
ated by generation of hepatotoxic metabolites in the phase
I of drug metabolism that often leads to the mitochondrial
inhibition and accumulation of reactive oxygen species
(ROS). Oxidative stress in hepatocytes finally results in
apoptosis and necrosis of cells [3, 4]. Considering the role
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of oxidative stress in pathogenesis of a wide range of liver
diseases, natural antioxidant products, especially phyto-
chemicals, are widely used in their treatment and nearly
half of the agents used in liver therapy today are either
natural products or their derivatives [5]. On the other
hand, the incidence of liver injuries due to herbal and
dietary supplements have risen largely in the past decade,
probably in part due to their growing consumption [2].
Thus, it is necessary to carefully determine the influence
of various herbal medicines on liver function, in both
normal and pathological conditions.
Thyme (Thymus vulgaris L., Lamiaceae), a small sub-
shrub native to the western Mediterranean region of
Europe, is commonly used as a culinary herb, but also for
different medicinal purposes. Antitussive, expectorant and
spasmolytic effects are considered to be the major pharma-
cological properties of thyme, and therefore it is used for
diseases of the upper respiratory tract, alone or in combin-
ation with other herbs [6]. The German Commission E ap-
proved internal use of thyme preparations for treating
symptoms of bronchitis, whooping cough and catarrh of
the upper respiratory tract [7]. Additional therapeutic prop-
erties of thyme include antioxidant [8] and antimicrobial
activity [9], genotoxic [10], anti-inflammatory [11], anal-
gesic and antipyretic effects [12], and antidiabetic effects
[13], among others. Several thyme preparations, such as
dried herb, liquid extract, elixir, and tincture, are included
in different official monographs, and they are commonly
added to formulations involving multiple herbal constitu-
ents, most often to syrups, but may be also incorporated in
tablets [14].
The main uses of thyme in culinary and food process-
ing are defined by its odour and taste, but also antioxi-
dant and antimicrobial activities. Food flavouring still
remains the main thyme application area in culinary,
while its antimicrobial and antioxidant properties can be
considered as the supplementary benefits of thyme prod-
ucts, which have been added to the foods [15].
Most pharmacological effects of thyme are the conse-
quence of its high antioxidant activity that is mainly attrib-
uted to the presence of phenolic monoterpenes, thymol
and carvacrol, as the major constituents of essential oil of
thyme. On the other hand, phenolic acid (rosmarinic acid)
and flavonoids (quercetin, eriocitrin, luteolin, and api-
genin) are proposed to be the polyphenolic compounds
responsible for the antioxidant effects of ethanolic and
aqueous extracts [16]. It should be noted that many plant
species, including thyme, contain individuals with distinct
composition of the secondary metabolites, i.e. chemical
phenotypes (chemotypes). Regarding the essential oils,
seven chemotypes have been described within Thymus
species, defined by the single dominant monoterpene pro-
duced: thymol, carvacrol, geraniol, α-terpineol, sabinene
hydrate, linalool, or 1,8-cineole [17]. Therefore, all effects
of thyme preparations should be carefully examined, tak-
ing into account the chemical composition.
Regarding the infuence of thyme and its constituents on
the liver, conflicting results have been reported in the lit-
erature. Although thyme has been listed as Generally
Recognized as Safe (GRAS) for use in food, it is known
that long-term or high-dose administration of thyme
preparations such as tinctures and essential oils that con-
tain thymol and carvacrol in high amounts, can be hep-
atotoxic [18]. Use of these products may aggravate
existing liver damage in humans [19]. On the contrary,
the hepatoprotective effects of thyme have been observed
in several experimental models of liver injury. The ethano-
lic and methanolic extracts of thyme have been effective
against aflatoxins- and N-nitrosodiethylamine (NDEA)-in-
duced oxidative liver damage, respectively [20, 21]. Thyme
extract and essential oil could ameliorate carbon tetra-
chloride (CCl4)-induced liver injury in rats [22]. The pro-
tective effects of aqueous extract [23] and essential oil
obtained from thyme [24] have been also demonstrated in
experimental model of paracetamol-induced liver damage.
Therefore, the objective of our study was to examine
the influence of two pharmaceutical formulations con-
taining thyme, tincture and syrup, which are commonly
used in humans, on CCl4-induced acute liver injury in
rats.
Methods
Thyme formulations and chemicals
Pharmaceutical formulations of thyme (Thymus vulgaris
L., Lamiaceae) used in this study were tincture and syrup.
They were obtained from the Institute for Studies on
Medicinal Plants ’Dr Josif Pančić’, Belgrade, Serbia, in
2012. A voucher specimen of the plant (Thymus vulgaris
L. 1753 subsp. vulgaris No 2–1516, det.: Goran Anačkov)
was confirmed and deposited in the Herbarium of the
Department of Biology and Ecology, Faculty of Sciences,
University of Novi Sad [25]. The tincture was made from
the aerial parts of the plant (Thymi herba) with 70 % etha-
nol in a 1:5 ratio of weight to volume. Thyme syrup consists
of thyme tincture (15 % w/w) and potassium bromide, sim-
ple syrup, methyl and propyl p-hydroxybenzoate as preser-
vatives, and water.
Carbon tetrachloride was obtained from Merck (Darm-
stadt, Germany). All chemicals for biochemical assays
were purchased from Sigma-Aldrich (St Louis, MO, USA).
Qualitative and quantitative analysis of thyme tincture
and syrup
The identification and quantification of thymol and
carvacrol, as main chemical constituents of thyme tincture
and syrup, were carried out by gas chromatography
coupled with mass spectrometric detection (GC/MS) and
flame ionization detection (GC/FID). GC/MS analysis was
Rašković et al. BMC Complementary and Alternative Medicine  (2015) 15:442 Page 2 of 11
performed using an Agilent 7890A GC system equipped
with 5975C VL MSD (Agilent Technologies, CA, USA).
The capillary column used in this study was DB-5MS
(30 m× 0.25 mm, film thickness of 0.25 μm; J&W Scien-
tific, CA, USA). The temperature program was set as
follows: initial temperature 50 °C held for 1 min, 5 °C per
min to 100 °C, 9 °C per min to 200 °C held for 7.89 min,
and the total run time was 30 min. The flow rate of helium
as a carrier gas was 0.811851 ml/min. The MS system was
operated in electron ionization (EI) mode with selected ion
monitoring (SIM). The ion source temperature and quad-
rupole temperature were set at 230 °C and 150 °C, respect-
ively. Identification of thymol and carvacrol was performed
by comparison of their retention times and mass spectra
with those of authentic standards and with spectra in the
NIST08.L and Wiley7n.l libraries.
GC/FID analysis was carried out using a Hewlett Pack-
ard 6890 chromatograph equipped with flame ionization
detector, autosampler and a split/splitless injection system.
The column DB-5MS (60 m × 0.32 mm, film thickness of
0.25 μm; J&W Scientific, CA, USA) and helium as a car-
rier gas with flow rate of 1.9 ml/min were used in this
analysis. Samples in volumes of 1 μl were injected in a
split mode (split ratio, 2.5:1). The injector and detector
temperatures were set at 250 °C and 300 °C, respectively,
and the column temperature program was set as follows:
initial temperature 60 °C held for 1 min, 10 °C per min to
265 °C held for 8.5 min, with the total run time of 30 min.
The concentrations of thymol and carvacrol were deter-
mined using the calibration curves prepared with stan-
dards of thymol and carvacrol, and cumene as internal
standard.
Evaluation of in vitro antioxidant activity and total
phenolic content of thyme tincture
Antioxidant activity of the tincture of thyme was evaluated
as free radical scavenging capacity (RSC). The ability of
tincture to donate an electron and scavenge the stable 1,1-
diphenyl-2-picrylhydrazyl (DPPH) radical was investigated
[26]. The tincture of thyme and aqueous solution of ascor-
bic acid, as a positive control, were mixed with DPPH
solution and after 60 min, remaining amount of the
purple-colored DPPH radical was measured spectrophoto-
metrically at 515 nm. Free radical scavenging capacity was
calculated as follows: RSC = 100–100 * Asample/Ablank,
where Ablank is the absorbance of diluted DPPH solution
and Asample is the absorbance of the tincture or refer-
ence. The IC50 value, which represents the concentrations
of the sample required to cause 50 % inhibition of DPPH
radical, was estimated by linear regression analysis from
the obtained RSC values and was expressed in mg/ml.
Phenolic content of tincture was determined using the
Folin-Ciocalteu reagent [27]. The tincture was mixed with
Folin-Ciocalteu reagent and sodium carbonate solution in
test tube. After being vortexed and incubated in dark for
2 h, absorbance was measured at 740 nm. The result was
expressed as mg of gallic acid equivalents (GAE) per liter.
Experimental design
The experiment was performed on 7–8 week old albino
Wistar rats of both sexes, weighing 230–300 g, obtained
from Military Medical Academy, Belgrade. The rats were
housed in standard laboratory cages, under a 12 h light-
dark cycle, at a constant ambient temperature (23 °C) and
humidity (30–50 %), and were allowed to adapt for 2 weeks
before the experiments were started. The animals were
maintained on standard pellet diet (LM2, Veterinary Insti-
tute, Subotica, Serbia) and allowed access to tap water ad
libitum. Animal care and all experimental procedures
were conducted in accordance with the Guide for the Care
and Use of Laboratory Animals edited by Commission of
Life Sciences, National Research Council (USA). The
study was approved by the Ethical Committee of the
University of Novi Sad (Approval No. 01-53/7-1).
To evaluate the effects of thyme formulations on CCl4-
induced liver injury, the animals were randomly divided
into six experimental groups, each containing six individ-
uals, and treated as follows:
 Con S: Control group, saline 1 ml/kg p.o.
 Con CCl4: saline 1 ml/kg p.o. + a single CCl4 dose
1 ml/kg i.p.
 Tin: thyme tincture 0.18 ml/kg p.o.
 Tin + CCl4: thyme tincture 0.18 ml/kg p.o. + a single
CCl4 dose 1 ml/kg i.p.
 Syr: thyme syrup 5.6 ml/kg p.o.
 Syr + CCl4: thyme syrup 5.6 ml/kg p.o. + a single
CCl4 dose 1 ml/kg i.p.
Applied daily doses of thyme tincture and syrup for rats
were 0.18 ml/kg and 5.6 ml/kg, respectively. Recom-
mended human daily doses of thyme tincture and syrup
for a male of approximately 70 kg weight [28] were
adapted for the experimentation on rats using FDA guid-
ance [29]. Thyme preparations were administered every
day for seven days by per os gavage, previously diluted
with saline. On the 7th day, 1 h after the last dose of
thyme preparations or saline, animals were treated intra-
peritoneally with CCl4 dissolved in olive oil (1:3, 1 ml/kg)
[30]. After 24 h, rats were anesthetized with urethane
(0.75 mg/kg) and sacrificed by cardiopunction, and the
samples of blood and liver were taken. The obtained
serum was used for determination of standard biochem-
ical parameters. Liver homogenates were prepared from
1 g of liver tissues which were homogenized in a Potter
homogenizer with Tris-HCl sucrose buffered solution in a
ratio 1:3 (w/v) at 4 °C. The parameters of oxidative stress
were analyzed in obtained liver homogenates.
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Serum biochemical parameters determination
Total cholesterol and triglycerides levels, concentration of
bilirubin, activities of alanine aminotransferase (ALT) and
aspartate aminotransferase (AST), and the concentrations
of urea and creatinine were determined in serum using
commercially available kits based on the well-established
spectrophotometric methods, according to the manuals
supplied. All analyses were performed in triplicate for
every sample on the Olympus AU 400 autoanalyzer
(Hamburg, Germany).
Determination of oxidative status in the liver
Oxidative status in the liver was estimated by measuring
the levels of lipid peroxidation (LPx), and the activities
of oxidative stress-related enzymes, including catalase
(CAT), peroxidase (Px), glutathione peroxidase (GPx),
glutathione reductase (GR) and xanthine oxidase (XOD)
in liver homogenates, using the spectrophotometric
methods.
The intensity of LPx was estimated by measuring the
amount of malondialdehyde, a terminal product of lipid
breakdown due to peroxidation damage, using the method
of Buege and Aust, 1978 [31]. XOD activity determination
method was based on the measuring the rate of methylene
blue reduction [32]. CAT activity was determined by the
method based on monitoring the H2O2 decomposition
rate at 240 nm [33], and Px activity by using guaiacol as
the enzyme’s substrate [34]. The activities of GPx and GR
were determined following the methods of Beutler, 1984
[35] and Goldberg and Spooner, 1983 [36], respectively.
These tests were based on the measuring the decrease in
absorbance caused by the oxidation of NADPH at 340 nm
(UV assay).
Histological assessment
Liver morphology was characterized by light microscopy
using routine hematoxylin and eosin (H&E) staining.
Twenty-four hours after administering CCl4, a small
piece of hepatic tissue was removed for histological
analysis. Liver tissue samples from each rat were fixed in
Bouin’s solution for 24 h, then dehydrated in a graded
series of isopropyl alcohol, and embedded in paraffin
blocks. Five-micrometer tissue sections were cut using a
rotation microtome (Leica Microsystems) in triplicate
for each animal, and stained with hematoxylin and eosin
for histological analysis under Olympus BX-43 light
microscope (Olympus, Japan) with an attached Olympus
DP 73 video camera (Olympus, Japan).
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). The intergroup variation between various groups
was measured by one-way analysis of variance (ANOVA)
followed by Tukey’s multiple comparison test. Results
were considered statistically significant when p < 0.05.
Data were analyzed using SPSS software, version 19
(IBM SPSS, Chicago, IL, USA).
Results
Concentrations of thymol and carvacrol in thyme
preparations
Thymol and carvacrol, as the major phenolic active
compounds of thyme, were identified and quantified in
examined thyme formulations by GC/MS. Thymol con-
centrations of 175.3 μg/ml and 9.73 μg/ml were mea-
sured in tincture and syrup, respectively. Concentrations
of carvacrol were much lower than those of thymol in
both formulations, and they were 10.54 μg/ml and
0.55 μg/ml in tincture and syrup, respectively. GC/MS
chromatograms of thymol and carvacrol standards and
thyme syrup are shown in Fig. 1. Peaks 1 and 2 were
identified as thymol and carvacrol at retention times of
15.819 and 16.002 min, respectively. Monitored ions (m/
z values) used for quantification and confirmation, and
retention times of thymol and carvacrol in GC/MS ana-
lysis are presented in Table 1.
In vitro antioxidant activity of thyme tincture
The antioxidant activity of thyme tincture was evaluated
by the DPPH free radical scavenging test and the result
was presented by IC50 value, defined as the concentration
of the antioxidant required to scavenge 50 % of DPPH
present in the test solution. The results demonstrated that
investigated tincture had a strong radical scavenging activ-
ity with an IC50 value of 0.169 mg/ml. A comparison was
made with ascorbic acid (vitamin C), well-known potent
antioxidant and free radical scavenger, which exhibited
IC50 value of 0.642 μg/ml. According to that, 1 mg of
ascorbic acid was found to be equivalent to 263.2 mg of
the thyme tincture.
Antioxidant activity of thyme was reported to be derived
mostly from the presence of phenolic compounds, particu-
larly thymol and carvacrol. We measured total phenolic
content in order to determine the extent of contribution of
these chemical compounds to free radical scavenging cap-
acity of thyme tincture. Total phenolic content of investi-
gated tincture was measured using the Folin-Ciocalteu
method and the high amount of total phenols (4859.77 mg
GAE/l) was determined.
Influence of thyme preparations on CCl4-induced serum
biochemical parameters
Biochemical parameters, related to hepatic and renal func-
tion, were determined in serum of rats and the results are
presented in Table 2. Cholesterol and triglycerides levels
were examined in order to evaluate the effect of thyme
preparations on metabolic function of the liver. Triglycer-
ides concentrations were significantly decreased in serum
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of CCl4-treated animals. Thyme tincture and syrup could
partially revert those values, but they were still signifi-
cantly lower than those of saline-treated group. CCl4-
induced a slight decrease in cholesterol levels, which was
partially recovered after administration of thyme tincture.
The intake of thyme preparations alone did not affect
significantly the metabolic function of the liver. Impaired
excretory function of the liver was observed after treat-
ment of animals with CCl4, which is indicated by signifi-
cant increase in both total and direct bilirubin levels in
serum, compared to the control group. Co-administration
of thyme formulations partially recovered bilirubin levels,
while administration of thyme tincture and syrup alone
did not change significantly these values when compared
to saline-treated group.
The extent of hepatocellular damage was assessed by
measuring activities of AST and ALT in serum, which were
increased 7- and 3-fold respectively in CCl4-treated group,
compared to the control group. This effect was additionally
exacerbated after the co-treatment with thyme tincture. On
the contrary, co-administration of thyme syrup reduced the
values of ASTand ALT in serum, compared to CCl4-treated
animals. Activities of these enzyme markers of liver injury
were not significantly changed in animals treated only with
thyme preparations compared to the control group.
Concentrations of urea and creatinine, as indicators of
renal function, were also determined in serum. Nephro-
toxic potential of CCl4 has been observed, since it induced
a slight decrease in urea and creatinine levels, which were
not significantly changed after co-treatment with thyme
preparations. The intake of thyme tincture and syrup
alone did not affect significantly renal excretory function.
Influence of thyme preparations on CCl4-induced
oxidative stress parameters in liver
In the present study, we aimed to evaluate the effects of
thyme on CCl4-induced liver injury and to explore whether
its mechanism of action is associated with modulation of
hepatic oxidative status. Thus, we measured malondialde-
hyde (MDA) levels and activities of xanthine oxidase
(XOD), catalase (CAT), peroxidase (Px), glutathione perox-
idase (GPx), and glutathione reductase (GR), as biomarkers
of the effects of studied thyme formulations, and the re-
sults are presented in Fig. 2.
The single dose of CCl4 induced 5-fold increase of
hepatic MDA level, when compared to the control group.
Co-treatment with both thyme tincture and syrup during
7 days succeeded to decrease MDA significantly in liver
tissue, compared to CCl4-treated group. The intake of
thyme preparations alone induced a slight increase in MDA
levels, but it was not statistically significant. The activity of
pro-oxidant XOD enzyme was changed in a similar manner
after treatment of animals with CCl4 and thyme prepara-
tions. XOD activity was significantly elevated in CCl4-
treated group, while co-treatment with thyme tincture and
syrup could significantly reduce activity of this enzyme. In
animals co-treated with thyme syrup, XOD activty
remained significantly higher when compared to that of
saline-treated group.
Oxidative stress induced by CCl4 resulted also in a
modification of antioxidant enzymes activities in the
liver. Activities of CAT, Px, and GR were significantly re-
duced in CCl4-treated animals, compared to the control
group, while GPx showed significantly increased activity
Fig. 1 GC/MS chromatograms of thymol and carvacrol standards (a) and thyme syrup (b)
Table 1 GC/MS parameters used for determination of thymol
and carvacrol in thyme tincture and syrup




Thymol 135 150; 91 and 115 15.819
Carvacrol 135 150; 91 and 107 16.002
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Table 2 Effects of thyme tincture and syrup on biochemical parameters in serum
Con S Con CCl4 Tin Tin + CCl4 Syr Syr + CCl4
Triglycerides (mmol/l) 1.31 ± 0.24 0.34 ± 0.05 a 0.89 ± 0.16 0.51 ± 0.10 a 1.29 ± 0.20* 0.59 ± 0.05 a
Cholesterol (mmol/l) 1.88 ± 0.25 1.38 ± 0.06 1.87 ± 0.32 1.56 ± 0.07 1.95 ± 0.17 1.37 ± 0.12
Total bilirubin (μmol/l) 2.18 ± 0.10 3.08 ± 0.17 a 2.33 ± 0.18 2.62 ± 0.31 1.98 ± 0.07* 2.52 ± 0.10
Direct bilirubin (μmol/l) 0.17 ± 0.02 0.58 ± 0.04 a 0.37 ± 0.07 0.52 ± 0.12 a 0.25 ± 0.06* 0.40 ± 0.03
AST (U/l) 127.3 ± 7.2 859.3 ± 160.3 a 199.8 ± 46.3* 1430.7 ± 285.3 a 120.0 ± 5.8* 626.7 ± 108.5
ALT (U/l) 47.3 ± 3.8 144.5 ± 32.2 a 48.0 ± 3.5* 209.8 ± 38.5 a 41.0 ± 1.9* 101.3 ± 16.3
Urea (mmol/l) 9.22 ± 0.44 10.47 ± 0.35 9.15 ± 1.07 10.75 ± 0.30 10.67 ± 0.47 8.95 ± 0.78
Creatinine (μmol/l) 45.50 ± 0.72 50.67 ± 1.12 45.00 ± 1.65* 51.33 ± 1.02 a 44.17 ± 0.60* 50.17 ± 1.89
All values are expressed as mean ± SEM
asignificantly different from Con S group; *significantly different from Con CCl4 group; p < 0.05
Fig. 2 Levels of lipid peroxidation (LPx), xantine oxidase (XOD), catalase (CAT), peroxidase (Px), glutathione peroxidase (GPx), and glutathione
reductase (GR) in liver homogenates. (*) significantly different from Con S group; (#) significantly different from Con CCl4 group; p < 0.05
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in the liver. Co-administration of thyme preparations
restored activities of CAT and Px towards normal values,
and these increases were more pronounced in the group
co-treated with tincture than with syrup. Thyme prepa-
rations significantly reduced the activity of GPx when
applied with CCl4 in comparison to animals treated only
with CCl4, and the tincture and syrup exerted these ef-
fects in a similar manner. On the other hand, the intake
of thyme tincture alone resulted in significant increase
of GPx, while syrup did not have that effect. Thyme
tincture, when applied alone, also induced significant
elevation of hepatic GR activity in comparison to both
saline- and CCl4-treated animals, while that activity was
not significantly changed in other studied groups.
Influence of thyme preparations on liver histology
The general liver morphological changes were examined by
standard H&E staining. Histopathological examination of
liver sections of control group showed normal cellular
architecture with distinct hepatic cells, sinusoidal spaces
and central vein. Hepatocytes were well formed with homo-
geneous cytoplasm and regular sized, centrally located nu-
clei. The sinusoidal capillaries were normal-sized without
lymphocytic infiltrate. Hepatic artery, portal vein and bile
ducts could be observed in portal spaces (Fig. 3a). Seven-
day treatment of rats with thyme tincture resulted in non-
observable changes of liver histology in comparison to
saline-treated animals (Fig. 3c).
Histopathological studies of liver sections of CCl4-in-
toxicated rats, alone and in combination with thyme
tincture, showed similar histopathological findings of
steatosis or steatohepatitis. Most of hepatocytes contain
lipid droplet that may be either macrovesicular or
microvesicular (Fig. 3b,d). In some cases mild inflamma-
tion was present in portal spaces, while numerous hepa-
tocytes are ballooned. These changes in the hepatic
architecture were not observed in any of the control rats
or animals treated with thyme tincture alone. Thyme co-
treatment could not improve CCl4-induced morphological
changes, since no significant histological differences were
observed between rats treated with CCl4 alone and in
combination with thyme tincture (Fig. 3d).
Discussion
In the present study, we evaluated antioxidant activity of
thyme preparations and their influence on hepatic function
using the hepatotoxicity model induced by CCl4. The con-
centrations of main active constituents of thyme, thymol
and carvacrol, were determined, and thymol was found to
be predominant, with approximately 16 times higher con-
centration in comparison to carvacrol, in both tincture and
syrup.
Antioxidant activity of thyme and its extracts is
dependent mainly on essential oil content and compos-
ition. It was demonstrated that phenolic chemotype of
thyme had a stronger antioxidant potential than a non-
Fig. 3 Photomicrographs of the liver sections stained with standard H&E technique taken at the magnification of 200x. a sections from control
animals (portal triad elements, PV—portal venule, HA—hepatic arteriole, B—bile ductule); b animals treated with CCl4 alone (C—central vein,
Mv-ld—macrovesicular lipid droplet); c thyme tincture alone (portal triad elements, PV—portal venule, HA—hepatic arteriole, B—bile ductule);
and d sections from animals treated with both CCl4 and thyme tincture (μv-ld—microvesicular lipid droplet, ballooned hepatocytes, inflammation
in portal tracts)
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phenolic chemotype, and that thymol and carvacrol
mostly contributed to the antioxidant activity of thyme.
Oxidation products of thymol, such as thymoquinone
and thymohydroquinone, are even more potent antioxi-
dants than thymol, as tested with several different
methods [8, 37].
Many in vitro studies confirmed antioxidant properties
of thyme extracts. It was shown that thyme extract had
stronger scavenging activity towards both DPPH and
ABTS radicals and higher total phenolic content, in
comparison to sage and stinging nettle [38]. Similiarly,
extracts of thyme, sage, and marjoram prepared using
methanol, ethanol, diethyl ether and hexane were exam-
ined using DPPH assay, and methanolic thyme extract
had the lowest IC50 value, i.e. exhibited the strongest
antioxidant capacity [39]. Tinctures of eleven plants used
as spices, including thyme, were tested for their antiradi-
cal properties by means of the DPPH assay over a 2 year
period, and thyme exhibited stable antioxidant activity
indicated by little variation in scavenging activity after 1
year [40].
The phenolic concentrations in ethanolic thyme extracts
in different studies, calculated as mg GAE per gram of dry
weight ranged from 3.36 [41] to 7.30 [39]. In our study,
high amount of total phenols of 4859.77 mg GAE/l was
measured, and that is in accordance with the results of the
study of Kulišić et al., 2006 [42] who determined total
phenolic content of 2000 mg GAE/l and 4400 mg GAE/l
in aqueous tea infusions obtained from thyme and wild
thyme, respectively. The discrepancy between results of
different studies can be attributed to several factors, in-
cluding geographical location of the plant, parts of plants
used for extracts preparation, extraction protocol, such as
solvent, temperature, and time [10].
The influence of thyme preparations on CCl4-induced
liver injury was determined by assessing serum levels of
aminotransferases (AST and ALT). In our study, hepatotox-
icity induced by CCl4 was reflected by a marked elevation
of AST and ALT activities, but also by notable histopatho-
logic alterations. Significant elevation of ALT and AST in
serum after administration of CCl4 indicates a loss of the
structural and functional integrity of the liver, and the
release of these cytoplasmic enzymes into systemic circula-
tion. In addition, our results reported increased level of
serum bilirubin, thereby suggesting impaired excretory
function of the liver. This is in agreement with the results
of many earlier studies using a model of CCl4-induced liver
damage. In this work, necrosis of hepatocytes was con-
firmed histologically.
Administration of thyme preparations alone did not
change significantly biochemical nor histological markers
of hepatic function, when compared to saline-treated
group. On the other hand, co-administration of thyme
tincture resulted in unexpected exacerbation of AST and
ALT values in serum, while thyme syrup managed to
reduce activites of aminotransferases, in comparison to
CCl4-treated animals. Opposing effects of thyme tincture
and syrup on the liver suggest that the dose of tincture is
too high, since it is known that herbal polyphenols in high
concentrations and under some circumstances such as the
presence of transition metals or peroxidases, can become
pro-oxidants and cause cytotoxicity and liver damage
through generation of ROS [43]. Besides, thymol and
carvacrol, as main active constituents of thyme, are mono-
terpenes, which principally do not exhibit dose-dependent
effects and for which is necessary to find the most appro-
priate dose range that shows effectiveness [44].
Previous studies demonstrated that oral administration
of a concentrated ethanolic extract of thyme in subacute
toxicity tests resulted in increased weights of liver in
mice [6]. Furthermore, in the study of Liu et al., 2011
[45], 16 phenolics and five botanical extracts, including
methanolic thyme extract, were evaluated in both a hu-
man and a rat hepatocyte cell line using a battery of
eight endpoints, covering a variety of biological activities
relevant to hepatotoxicity. Cluster analysis was used to
group the phenolics and extracts, and thyme extract
clustered in the presumptive hepatotoxic group in rat
MH1C1 hepatoma cells, but not in human HepG2/C3A
cells. On the contrary, the hepatoprotective effects of
thyme have been observed in experimental models of
liver injury induced by paracetamol [24], NDEA [21],
and aflatoxins [20]. Likewise, dietary supplementation of
thyme extract to rats during 8 weeks was able to ameli-
orate the acute hepatotoxicity caused by CCl4 [22]. The
results of our study differ from these results, and that
can be explained by differences in applied doses and
treatment periods. Hepatoprotective activity has been
also demonstrated for main thyme constituents. Thymol
ameliorated CCl4-induced liver injury in mice and it was
suggested that it suppressed cytochrome P450 mediated
metabolic activation of CCl4 [46]. Furthermore, carva-
crol exerted antioxidant and hepatoprotective effects in
a model of D-galactosamine-induced hepatotoxicity in
rats [47].
Promising results in terms of antidiabetic activity of
thyme have been observed in both streptozotocin [13] and
alloxan models [48] of diabetes mellitus in rats, suggesting
its potential use in the treatment of metabolic syndrome.
The intake of thyme extract managed to reduce serum
concentrations of cholesterol and triglycerides, but we did
not observe these effects. Seven-day treatment of rats with
thyme tincture resulted in reduction of triglycerides levels
in serum, but it was not statistically significant.
In addition to determination of hepatic function, the
influence of thyme preparations on renal function has
been also investigated in our study. CCl4 induced a slight
decrease in urea and creatinine levels in serum of rats.
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In our previous studies [49, 50], CCl4 was applied in a
higher dose (1 ml/kg) that exerted more pronounced
nephrotoxic effects indicated by significant increase of
urea and creatinine concentrations in serum. The pa-
rameters of renal function were not significantly chan-
ged after co-treatment with thyme preparations, which
is in accordance with results of the study of Ozkol et al.,
2013 [13]. On the other hand, significant nephroprotec-
tive activity was demonstrated for thyme in aflatoxin-
intoxicated rats [51].
Considering the role of oxidative stress in etiopatho-
genesis of liver injury induced by most xenobiotics, we
evaluated the influence of pharmaceutical formulations
containing thyme on lipid peroxidation and endogenous
antioxidant defense system in liver. We used the model
of acute liver damage induced by CCl4, since this com-
pound is metabolized via reductive dehalogenation in-
volving cytochrome P450, resulting in formation of ROS
that cause the peroxidation of membrane lipids. Admin-
istration of CCl4 induced significant elevation of hepatic
levels of MDA, a major secondary product of lipid per-
oxidation and indicator of cell membrane injury (Fig. 2).
Co-administration of thyme preparations managed to
prevent CCl4-induced increase of MDA, suggesting their
ability to preserve cellular integrity. Similar to our
results, it was shown that dietary supplementation of
thyme extract and essential oil during 8 weeks was able
to ameliorate CCl4-induced lipid peroxidation in liver of
rats [22]. CCl4 also increased the activity of pro-oxidant
enzyme XOD that forms superoxide anion radical and
hydrogen peroxide, and the intake of thyme significantly
reversed these activities towards normal values.
The activities of antioxidant enzymes were also signifi-
cantly changed after administration of CCl4 (Fig. 2). This
toxicant induced a significant reduction of CAT, Px and
GR activities, which can be explained by their inactiva-
tion induced by excessive production of free radicals. On
the other hand, activity of GPx was increased in the liver
after administration of CCl4. Similar results were ob-
tained in our previous study [49] and the study of Hsiao
et al., 2003 [52], where the increase of GPx activity and
reduction of CAT activity were demonstrated after CCl4
treatment. It is well known that CAT has an important
role in the elimination of ROS derived from the redox
process of xenobiotics in the liver, and that it is easily
inactivated by lipid peroxides. On the other hand, under
oxidative stress conditions, GPx can be upregulated as
the adaptive response of the hepatocytes to oxidative
damage and its activity can be increased [53]. In several
studies [20, 22], all antioxidant enzymes were decreased
after application of CCl4, but these differences may be
attributed to different treatment protocols.
Antioxidant activity of thyme has been ascertained in
several in vivo models, beside models of liver damage.
The essential oil and particularly aqueous tea infusion ob-
tained from thyme exerted a protective role on copper-
induced LDL oxidation [54]. Furthermore, aqueous extracts
of thyme could prevent inhibition of glucose-6-phosphate
dehydrogenase activity in erythrocytes and subsequent
hemolysis caused by nitrosative stress [55]. Several studies
investigated the influence of thyme on antioxidant status,
including activities of antioxidant enzymes. It has been
demonstrated that rats whose diets were supplemented
with thyme oil retained higher antioxidant capacity during
their life span by preventing the unfavourable age-related
decline in activities of SOD in the liver and heart of old rats
[56]. Likewise, oral administration of ethanolic extract of
thyme enhanced plasma antioxidant status in healthy rats,
and it was also shown that protection against oxidative
stress by thyme occured primarily through direct antioxi-
dant effects of its main constituents, but that it may be
also related to the phenolic metabolites, such as thymol
sulfate [57].
The results of our study have determined that thyme
mediates its antioxidant activity through both direct free
radical scavenging and activation of physiological defense
mechanisms. Despite demonstrated antioxidant activity,
thyme preparations unexpectedly could not ameliorate
liver injury in rats. The role of oxidative stress in liver
injuries is highly significant, but it should be emphasized
that several other pathophysiological mechanisms of
drug-induced hepatotoxicity have been shown to be in-
volved, including inflammatory processes. Although anti-
inflammatory effects of thyme have been demonstrated in
vivo, the isolated active compounds thymol and carvacrol
have shown antagonistic effects. It is known that thymol
may have an irritative effect that likely involves histamine
and prostanoids, contrary to carvacrol with established
anti-inflammatory activity [11]. Given that thymol was
found to be the predominant active compound in investi-
gated thyme preparations in our study, the role of inflam-
matory processes may explain our results, although a
more in-depth evaluation of the mechanisms involved
should be examined.
Conclusions
Pharmaceutical formulations containing thyme may aggra-
vate existing hepatotoxicity, probably through involvement
in cellular inflammatory processes. The lack of clinical
safety and toxicity data for thyme, and many other herbs
that are increasingly being used, suggests the necessity of
further investigations regarding their influence on hepatic
function, including the evaluation of molecular mecha-
nisms involved in order to exploit them for potential thera-
peutic benefits.
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